During the 2024–2025 biennium, PAHO played a key role in restoring Venezuela’s access to PAHO’s Regional Revolving Funds for the procurement of essential vaccines, after seven years of inactivity.  

Through continuous technical and operational support, PAHO assisted the country in reactivating the administrative and programmatic processes necessary to rejoin this regional mechanism, enabling the acquisition of 2.75 million doses of essential vaccines. This achievement directly contributed to strengthening the sustainability of the national immunization program, ensuring timely access to quality vaccines, and reducing the health system’s vulnerability to supply disruptions. The restoration of access to the Regional Revolving Funds strengthened the country’s capacity to protect the population, in particular children, against vaccine-preventable diseases and laid a stronger foundation for sustaining progress in the elimination of communicable diseases.  

The outcome improved access to essential health supplies for all and contributed to the gradual recovery of critical functions within the public healthcare system, aligning with the Disease Elimination initiative, which in Venezuela seeks to address both communicable and noncommunicable diseases (NCDs), mental health, intentional and unintentional injuries, and violence.